Cationic Amphiphilic

General Information


DRACP ID  DRACP00320

Peptide Name   Cationic Amphiphilic

Sequence  GIIKKIIIKKIIIKKI

Sequence Length  16

UniProt ID  Not available

PubChem CID  Not available

Origin  AMP

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50=15 µM WST-1 assay Not available 1
HL-60 Adult acute myeloid leukemia; Acute myeloid leukemia Leukemia IC50=25 µM WST-1 assay Not available 1

Hemolytic Activity  Human red blood cells: over the active concentration ranges against bacteria and cancer cells, there is little activity or toxicity against hRBCs

Normal (non-cancerous) Cytotoxicity  NIH 3T3: low toxic

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00320

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C92H176N22O17

Absent amino acids  ACDEFHLMNPQRSTVWY

Common amino acids  I

Mass  213031

Pl  11.5

Basic residues  6

Acidic residues  0

Hydrophobic residues  9

Net charge  6

Boman Index  1192

Hydrophobicity  104.38

Aliphatic Index  219.38

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 21955251

Title  Designed antimicrobial and antitumor peptides with high selectivity

Doi 10.1021/bm201098j

Year  2011

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.